IL-7 mediated upregulation of VLA-4 increases accumulation of adoptively transferred T lymphocytes in murine glioma.
The efficacy of T cell-dependent immunotherapies against glioma is limited by few intra-tumoral lymphocytes and tumor-induced T cell sequestration. We considered whether peripheral autologous lymphocyte transfer (ALT) could boost Central Nervous System (CNS) T cell counts in established glioma. We found that ALT lymphocytes specifically entered tumor tissue while endogenous T cell counts fell. T cells expanded with IL-7 demonstrated an enhanced ability to accumulate in established murine glioma compared to IL-2. Increased entry was not phenotype dependent. Instead, IL-7 upregulates the migratory integrin VLA-4 on mouse and human T cells. VLA-4 expression was also high on endogenous T cells in established tumors. Intracranial (IC) VLA-4 blockade retained T cells in the brain but did not yield any survival benefit. IC VLA-4 blockade also reduced the cytotoxicity of immunotherapies in vitro. However, combination IL-7 ALT (VLA-4Hi) & α4-1BB antibody therapy extended median survival for animals with orthotopic glioma compared to monotherapy. Similarly, IL-7 expanded hPBMCs & brain bi-specific T cell engagers targeting EGFRvIII (BRiTE) extended survival. We conclude that IL-7 upregulates VLA-4 on T cells, facilitating their accumulation in IC glioma. Seeding gliomas with infiltrative T cells is a potential therapeutic strategy to enhance the efficacy of T-cell dependent therapies..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
bioRxiv.org - (2024) vom: 02. Apr. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Singh, Kirit [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2024.04.01.587634 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI043139655 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI043139655 | ||
| 003 | DE-627 | ||
| 005 | 20240405120344.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240403s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2024.04.01.587634 |2 doi | |
| 035 | |a (DE-627)XBI043139655 | ||
| 035 | |a (biorXiv)10.1101/2024.04.01.587634 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Singh, Kirit |e verfasserin |0 (orcid)0000-0002-0419-5381 |4 aut | |
| 245 | 1 | 0 | |a IL-7 mediated upregulation of VLA-4 increases accumulation of adoptively transferred T lymphocytes in murine glioma. |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The efficacy of T cell-dependent immunotherapies against glioma is limited by few intra-tumoral lymphocytes and tumor-induced T cell sequestration. We considered whether peripheral autologous lymphocyte transfer (ALT) could boost Central Nervous System (CNS) T cell counts in established glioma. We found that ALT lymphocytes specifically entered tumor tissue while endogenous T cell counts fell. T cells expanded with IL-7 demonstrated an enhanced ability to accumulate in established murine glioma compared to IL-2. Increased entry was not phenotype dependent. Instead, IL-7 upregulates the migratory integrin VLA-4 on mouse and human T cells. VLA-4 expression was also high on endogenous T cells in established tumors. Intracranial (IC) VLA-4 blockade retained T cells in the brain but did not yield any survival benefit. IC VLA-4 blockade also reduced the cytotoxicity of immunotherapies in vitro. However, combination IL-7 ALT (VLA-4Hi) & α4-1BB antibody therapy extended median survival for animals with orthotopic glioma compared to monotherapy. Similarly, IL-7 expanded hPBMCs & brain bi-specific T cell engagers targeting EGFRvIII (BRiTE) extended survival. We conclude that IL-7 upregulates VLA-4 on T cells, facilitating their accumulation in IC glioma. Seeding gliomas with infiltrative T cells is a potential therapeutic strategy to enhance the efficacy of T-cell dependent therapies. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Hotchkiss, Kelly M |e verfasserin |4 aut | |
| 700 | 1 | |a Cook, Sarah L |e verfasserin |4 aut | |
| 700 | 1 | |a Noldner, Pamy |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Moelker, Eliese M |e verfasserin |4 aut | |
| 700 | 1 | |a Railton, Chelsea O |e verfasserin |4 aut | |
| 700 | 1 | |a Blandford, Emily E |e verfasserin |4 aut | |
| 700 | 1 | |a Puviindran, Bhairavy J |e verfasserin |4 aut | |
| 700 | 1 | |a Wallace, Shannon E |e verfasserin |4 aut | |
| 700 | 1 | |a Norberg, Pamela K |e verfasserin |4 aut | |
| 700 | 1 | |a Archer, Gary E |e verfasserin |4 aut | |
| 700 | 1 | |a Shaz, Beth |e verfasserin |4 aut | |
| 700 | 1 | |a Sampson, John H |e verfasserin |4 aut | |
| 700 | 1 | |a Khasraw, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Fecci, Peter E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 02. Apr. |
| 773 | 1 | 8 | |g year:2024 |g day:02 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2024.04.01.587634 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 02 |c 04 | ||